A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial

In Tanzania, Hemolysis after a Single Dose of Primaquine Coadministered with an Artemisinin Is Not Restricted to Glucose-6-Phosphate Dehydrogenase-Deficient (G6PD A-) Individuals

(2010) S. A. Shekalaghe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

(2010) Lucio Luzzatto   LANCET

Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial

(2010) Antoinette K Tshefu et al.   LANCET

Changes in the burden of malaria in sub-Saharan Africa

(2010) Wendy Prudhomme O'Meara et al.   LANCET INFECTIOUS DISEASES

Artemisinin combination therapy for vivax malaria

(2010) Nicholas M Douglas et al.   LANCET INFECTIOUS DISEASES

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

(2010) Frank Smithuis et al.   LANCET INFECTIOUS DISEASES

An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia

(2010) Neena Valecha et al.   PLoS One

Incidence of Malaria and Efficacy of Combination Antimalarial Therapies over 4 Years in an Urban Cohort of Ugandan Children

(2010) Tamara D. Clark et al.   PLoS One

Artemether‐Lumefantrine versus Dihydroartemisinin‐Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children

(2009) Emmanuel Arinaitwe et al.   CLINICAL INFECTIOUS DISEASES

Existing antimalarial agents and malaria-treatment strategies

(2009) Umberto D'Alessandro   EXPERT OPINION ON PHARMACOTHERAPY

Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

(2009) Jean Ndiaye et al.   MALARIA JOURNAL

Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria

(2009) Zul Premji et al.   PLoS One

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial

(2009) Quique Bassat et al.   PLoS One

Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission

(2009) André Lin Ouédraogo et al.   PLoS One

Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance

(2008) K. Stepniewska et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

(2008) Petra F Mens et al.   MALARIA JOURNAL

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials

(2008) Lucy C Okell et al.   MALARIA JOURNAL